AIRS vs. CDNA, PNTG, AVAH, CSTL, AUNA, GRAL, FLGT, TALK, INNV, and DCGO
Should you be buying AirSculpt Technologies stock or one of its competitors? The main competitors of AirSculpt Technologies include CareDx (CDNA), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Auna (AUNA), Grail (GRAL), Fulgent Genetics (FLGT), Talkspace (TALK), InnovAge (INNV), and DocGo (DCGO). These companies are all part of the "healthcare" industry.
AirSculpt Technologies vs.
CareDx (NASDAQ:CDNA) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, community ranking, analyst recommendations and dividends.
In the previous week, CareDx had 1 more articles in the media than AirSculpt Technologies. MarketBeat recorded 1 mentions for CareDx and 0 mentions for AirSculpt Technologies. CareDx's average media sentiment score of 0.50 beat AirSculpt Technologies' score of 0.00 indicating that CareDx is being referred to more favorably in the media.
CareDx received 429 more outperform votes than AirSculpt Technologies when rated by MarketBeat users. Likewise, 65.97% of users gave CareDx an outperform vote while only 36.67% of users gave AirSculpt Technologies an outperform vote.
CareDx has a beta of 1.86, suggesting that its share price is 86% more volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 1.71, suggesting that its share price is 71% more volatile than the S&P 500.
CareDx presently has a consensus target price of $28.33, suggesting a potential upside of 24.50%. AirSculpt Technologies has a consensus target price of $5.00, suggesting a potential upside of 3.43%. Given CareDx's stronger consensus rating and higher possible upside, analysts clearly believe CareDx is more favorable than AirSculpt Technologies.
91.5% of AirSculpt Technologies shares are held by institutional investors. 4.9% of CareDx shares are held by company insiders. Comparatively, 78.8% of AirSculpt Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
AirSculpt Technologies has lower revenue, but higher earnings than CareDx. AirSculpt Technologies is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks.
AirSculpt Technologies has a net margin of -4.13% compared to CareDx's net margin of -45.90%. AirSculpt Technologies' return on equity of 2.22% beat CareDx's return on equity.
Summary
CareDx beats AirSculpt Technologies on 11 of the 18 factors compared between the two stocks.
Get AirSculpt Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIRS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AirSculpt Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:AIRS) was last updated on 1/27/2025 by MarketBeat.com Staff
